477 results on '"Sundan, Anders"'
Search Results
2. Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence
3. Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells
4. Receptor binding competition: A paradigm for regulating TGF-β family action
5. Monoclonal immunoglobulins promote bone loss in multiple myeloma
6. Why do myeloma patients have bone disease? A historical perspective
7. Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cells
8. Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
9. Additional file 2 of FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
10. Additional file 5 of FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
11. Additional file 4 of FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
12. Additional file 6 of FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
13. Additional file 7 of FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells
14. The role of bone morphogenetic proteins in myeloma cell survival
15. Death of multiple myeloma cells induced by cAMP-signaling involves downregulation of Mcl-1 via the JAK/STAT pathway
16. A Method for Measurement of Drug Sensitivity of Myeloma Cells Co-Cultured with Bone Marrow Stromal Cells
17. HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase
18. A Gain-of-Function Mutation in EPO in Familial Erythrocytosis
19. Artesunate shows potent anti-tumor activity in B-cell lymphoma
20. Clonal evolution after treatment pressure in multiple myeloma:heterogenous genomic aberrations and transcriptomic convergence
21. A-kinase anchoring protein AKAP95 is a novel regulator of ribosomal RNA synthesis
22. OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus
23. Evidence That Diphtheria Toxin and Modeccin Enter the Cytosol from Different Vesicular Compartments
24. Imatinib inhibits proliferation of human mesenchymal stem cells and promotes early but not late osteoblast differentiation in vitro
25. Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells
26. Bone diesease in multiple myeloma
27. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma
28. Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells
29. Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate
30. Serglycin Constitutively Secreted by Myeloma Plasma Cells Is a Potent Inhibitor of Bone Mineralization in Vitro
31. Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease
32. IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cells
33. Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
34. The role of interleukin-2 in regulating the sensitivity of natural killer cells for Fas-mediated apoptosis
35. Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters
36. Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis
37. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
38. Role of hepatocyte growth factor and its receptorc-met in multiple myeloma
39. FGFR3 is expressed and is important for survival in INA-6, a human myeloma cell line without a t(4;14)
40. High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis
41. c-Met signaling promotes IL-6-induced myeloma cell proliferation
42. Mn2+ regulates myeloma cell adhesion differently than the proadhesive cytokines HGF, IGF-1, and SDF-1α
43. Lipopolysaccharide and Double-stranded RNA Up-regulate Toll-like Receptor 2 Independently of Myeloid Differentiation Factor 88
44. Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells
45. Apoptosis, proliferation and NF-κB activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor
46. Hepatocyte growth factor in serum after injection of unfractionated and low molecular weight heparin in healthy individuals
47. Bone Morphogenetic Protein 4 Gene Therapy in Mice Inhibits Myeloma Tumor Growth, But Has a Negative Impact on Bone
48. Glycosylationof Immunoglobulins Determine Bone Loss in Multiple Myeloma
49. Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model
50. Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.